Excessive-profile gene enhancing startup Tome Biosciences stated in a authorized submitting Friday that it’ll terminate just about its complete workers starting Nov. 1.
The Massachusetts WARN discover comes a day after STAT reported the corporate was in dire straits, with one supply saying that it deliberate to wind down operations and search a purchaser by Nov. 1 after the corporate struggled to lift cash or discover a accomplice.
Tome instructed STAT it was solely “working at decreased capability,” whereas “sustaining core experience” because it “discover[d] strategic choices.”
This text is unique to STAT+ subscribers
Unlock this text — plus each day protection and evaluation of the biotech sector — by subscribing to STAT+.
Have already got an account? Log in
Have already got an account? Log in
View All Plans
